Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
7.74
0.00 (0.00%)
At close: Sep 15, 2025, 4:00 PM EDT
7.55
-0.19 (-2.45%)
After-hours: Sep 15, 2025, 7:55 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $568.25 million as of September 15, 2025. Its market cap has decreased by -67.87% in one year.
Market Cap
568.25M
Enterprise Value
-283.05M
1-Year Change
-67.87%
Ranking
Category
Stock Price
$7.74
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $568.25M, an increase of 10.09%. That is a compound annual growth rate of 1.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 568.25M | -56.86% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | 4.09B | 159.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |